Dose-reduced versus standard conditioning followed by allogeneic stem-cell transplantation for patients with myelodysplastic syndrome: a prospective randomized phase III study of the EBMT (RICMAC trial)

DSpace Repository

Dose-reduced versus standard conditioning followed by allogeneic stem-cell transplantation for patients with myelodysplastic syndrome: a prospective randomized phase III study of the EBMT (RICMAC trial)

Author: Kroeger, Nicolaus; Iacobelli, Simona; Franke, Georg-Nikolaus; Platzbecker, Uwe; Uddin, Ruzena; Huebel, Kai; Scheid, Christof; Weber, Thomas; Robin, Marie; Stelljes, Matthias; Afanasyev, Boris; Heim, Dominik; Deliliers, Giorgio Lambertenghi; Onida, Francesco; Dreger, Peter; Pini, Massimo; Guidi, Stefano; Volin, Liisa; Guenther, Andreas; Bethge, Wolfgang; Poire, Xavier; Kobbe, Guido; van Os, Marleen; Brand, Ronald; de Witte, Theo
Tübinger Autor(en):
Bethge, Wolfgang Andreas
Published in: Journal of Clinical Oncology (2017), Bd. 35, H. 19, S. 2157-2164
Verlagsangabe: Amer Soc Clinical Oncology
Language: English
Full text: http://dx.doi.org/10.1200/JCO.2016.70.7349
ISSN: 1527-7755
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)